• Product Name : XELJANZ 5MG TABLET
  • Manufacturer Name : Pfizer Pharmaceuticals LLC/USA
  • Type : Import Product
  • Distributor Agent : Arab Company for Medical & Agricultural Products
  • Dosage Form : film coated tablet
  • Active Composition : Each tablet contains: Tofacitinib (as citrate) 5mg
  • Used For : XELJANZ is indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis who have had an inadequate response or intolerance to methotrexate. It may be used as monotherapy or in combination with methotrexate or other nonbiologic disease-modifying antirheumatic drugs (DMARDs). Limitation of use: XELJANZ in combination with biologic DMARDs or with potent immunosuppressants such as azathioprine and cyclosporine is not recommended.
  • Registration Number : 78/6739/28, 60
  • Registration Date : 10-01-2019
  • Validity Date : 10-01-2024

Please Wait